HEALTH PROFESSIONAL · SOURCE READING

Sclerosing Epithelioid Fibrosarcoma

Source: Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 21, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Fibroblastic and Myofibroblastic Tumors

Sclerosing epithelioid fibrosarcoma is a rare malignant sarcoma that commonly harbors EWSR1 gene fusions and has an aggressive clinical course. The tumor responds poorly to chemotherapy.[113,114]

Source links and citations

Continue within this section

Genomic characteristics →Treatment of sclerosing epithelioid fibrosarcoma →

Publication references

Read the original reference and check its publication notices.

PubMed 25231134 · Original source
PubMed 28939748 · Original source

Preserved source evidence · Not medical advice